why choose us

First received: September 21, 2023

Clinical Trial: Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Prostate Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: High Precision Stereotactic Radiotherapy to the Whole Prostate With Focal Boost and Varying Hormonal Therapy (HEATWAVE)

Brief Summary: This phase II trial evaluates apalutamide in combination with image-guided stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate cancer.Prostate cancer usually needs the hormone testosterone to grow.Apalutamide is a hormone therapy that blocks the effect of testosterone on prostate tumor cells.This may help stop the growth of tumor cells that need testosterone to grow.Image-guided SBRT is a standard treatment for some types of prostate cancer.This treatment combines imaging of…

Read more